Chairs: SL Ferrari, ML Bouxsein

Members: E Biver, C Glüer, M McClung

Co-opted: P Zysset

To review the experimental and clinical evidence evaluating femoral strength by BMD and/or finite element analysis (FEA), its correlation with the actual strength and its association with hip fracture risk and changes with osteoporosis treatment.

• Bouxsein ML, Zysset P, Glüer CC, McClung M, Biver E, Pierroz D, Ferrari SL, on behalf of the IOF Working Group on Hip Bone Strength as a Therapeutic Target. Perspectives on the non-invasive evaluation of femoral strength in the assessment of hip fracture risk. Osteoporos Int, 2020. doi:10.1007/s00198-019-05195-0